Guangxu Lan Selected Research

Guangxu Lan Research Topics

15	Neoplasms (Cancer) 10/2022 - 01/2018
3	Colonic Neoplasms (Colon Cancer) 10/2021 - 01/2017
3	Hypoxia (Hypoxemia) 04/2020 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2018
1	Breast Neoplasms (Breast Cancer) 11/2019

8	Metal-Organic FrameworksIBA 10/2022 - 01/2018
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2021 - 01/2017
4	Immune Checkpoint InhibitorsIBA 10/2020 - 01/2018
4	LigandsIBA 06/2020 - 01/2017
3	MetalsIBA 06/2020 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2020 - 01/2019
3	tributyl phosphate (TBP)IBA 01/2020 - 01/2018
3	B7-H1 AntigenIBA 11/2019 - 01/2018
2	OligodeoxyribonucleotidesIBA 10/2022 - 01/2020
2	Neoplasm Antigens (Tumor Antigens)IBA 11/2021 - 10/2020
2	Therapeutic UsesIBA 10/2020 - 01/2018
2	Hydroxyl RadicalIBA 04/2020 - 01/2020
1	zinc 1,4,8,11,15,18,22,25- octa- n- butoxyphthalocyanineIBA 10/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 10/2020
1	VaccinesIBA 10/2020
1	CatalaseIBA 04/2020
1	Oxygen (Dioxygen)IBA 04/2020
1	Superoxides (Superoxide)IBA 01/2020
1	AntigensIBA 01/2020
1	Singlet OxygenIBA 01/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2020
1	Photosensitizing Agents (Photosensitizers)IBA 10/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018
1	Immune Checkpoint ProteinsIBA 01/2018
1	2,2'-Dipyridyl (2,2 Bipyridine)IBA 01/2017
1	hydroxide ionIBA 01/2017
1	tris(2,2-bipyridine)-ruthenium(II)IBA 01/2017

7	Immunotherapy 10/2022 - 01/2018
6	Therapeutics 11/2021 - 01/2018
6	Radiotherapy 11/2021 - 01/2018
5	Photochemotherapy (Photodynamic Therapy) 10/2022 - 01/2017
1	Phototherapy (Light Therapy) 01/2019